Ekso Historical Cash Flow
| EKSO Stock | USD 0.44 0.01 2.22% |
Analysis of Ekso Bionics cash flow over time is an excellent tool to project Ekso Bionics Holdings future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Financing Activities of 12.3 M or End Period Cash Flow of 6.2 M as it is a great indicator of Ekso Bionics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Ekso Bionics Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ekso Bionics Holdings is a good buy for the upcoming year.
Ekso |
About Ekso Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Ekso balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Ekso's non-liquid assets can be easily converted into cash.
Ekso Bionics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Ekso Bionics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Ekso Bionics Holdings current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At this time, Ekso Bionics' Stock Based Compensation is very stable compared to the past year. As of the 30th of March 2025, Cash Flows Other Operating is likely to grow to about 4.2 M, though Change In Cash is likely to grow to (2 M).
Ekso Bionics cash flow statement Correlations
Click cells to compare fundamentals
Ekso Bionics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ekso Bionics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 2.0M | 27.5M | (19.9M) | (11.9M) | (2.1M) | (2.0M) | |
| Free Cash Flow | (8.8M) | (11.2M) | (14.9M) | (12.2M) | (9.8M) | (10.3M) | |
| Change In Working Capital | 1.1M | (468K) | (2.6M) | (583K) | (2.5M) | (2.4M) | |
| Begin Period Cash Flow | 10.9M | 12.9M | 40.4M | 20.5M | 8.6M | 16.2M | |
| Total Cash From Operating Activities | (8.8M) | (11.2M) | (14.7M) | (12.1M) | (9.8M) | (10.3M) | |
| Net Income | (15.8M) | (9.8M) | (15.1M) | (15.2M) | (11.3M) | (11.9M) | |
| Total Cash From Financing Activities | 10.7M | 38.7M | 176K | 348K | 7.8M | 12.3M | |
| End Period Cash Flow | 12.9M | 40.4M | 20.5M | 8.6M | 6.5M | 6.2M | |
| Other Cashflows From Financing Activities | 3.3M | 1.4M | (176K) | (157K) | 7.8M | 4.5M | |
| Other Non Cash Items | 319K | 134K | (647K) | (207K) | (1.5M) | (1.4M) | |
| Change To Inventory | 379K | (752K) | (1.4M) | 232K | 257K | 269.9K | |
| Stock Based Compensation | 2.6M | 2.5M | 2.7M | 2.2M | 1.4M | 2.6M | |
| Depreciation | 620K | 561K | 887K | 1.7M | 1.6M | 1.3M | |
| Change To Account Receivables | 1.8M | (1.6M) | (67K) | (1.2M) | (2.0M) | (1.9M) | |
| Change To Operating Activities | 1.6M | (766K) | (629K) | 860K | 989K | 497.5K | |
| Change To Netincome | (3.5M) | 2.1M | (1.5M) | 2.1M | 1.9M | 1.6M | |
| Change To Liabilities | (547K) | (1.3M) | 1.0M | (613K) | (551.7K) | (524.1K) | |
| Investments | 0.0 | (59K) | (5.2M) | (5.1M) | (37K) | (38.9K) | |
| Issuance Of Capital Stock | 7.1M | 37.3M | 0.0 | 661K | 9.0M | 9.1M |
Pair Trading with Ekso Bionics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.Moving together with Ekso Stock
Moving against Ekso Stock
| 0.81 | OCX | OncoCyte Corp | PairCorr |
| 0.7 | LUCD | Lucid Diagnostics | PairCorr |
| 0.65 | MNDR | Mobile health Network | PairCorr |
| 0.59 | GOSS | Gossamer Bio | PairCorr |
| 0.39 | PAVM | PAVmed Inc | PairCorr |
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.56) | Revenue Per Share | Quarterly Revenue Growth 0.05 | Return On Assets | Return On Equity |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.